Skip to content
Screener

ImmunityBio, Inc. IBRX Book value per share

Book value per share at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$34.82+7.3%
Gilead Sciences logo
Gilead SciencesGILD
$9.52-39.3%
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
$23.29+2,285%
Aura Biosciences, Inc. logo
Aura Biosciences, Inc.AURA
$1.59-37.7%
CG Oncology logo
CG OncologyCGON
$11.67+32.7%
Immunome logo
ImmunomeIMNM
$5.20+34.5%

Other financials

Income statement

See full
Revenue$44.2M+168%
Gross profit$44.0M+167%
Operating income-$69.8M-8.3%
Net income-$632.8M-388%
EPS (diluted)-$0.62-313%

Balance sheet

See full
Cash & equivalents$205.2M+238%
Total debt$445.4M+32.2%
Total equity-$870.0M-47.1%
Total assets$646.6M+113%

Cash flow

See full
Operating cash flow-$75.4M+12.3%
CapEx$1.8M+58.4%
Free cash flow-$77.1M+11.4%

Valuation

See full
Market cap$7.68B+242%
Enterprise value$7.92B+227%
P/S54.5×+14.8×

Profitability

See full
Gross margin99.3%-0.5pp
Operating margin-185.4%-83.3pp
Net margin-606.2%-212pp
FCF margin-212%-95.8pp

Returns & leverage

See full
Return on equity-119.3%
Debt / equity0.1×
Current ratio6.7×+4.4×

Where this comes from

Calculated from ImmunityBio, Inc.’s reported figures.

Based on the most recent quarter.

The source filing: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026. Open the filing →

Filed
May 7, 2026, 7:37 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001326110-26-000059

FAQ

What is ImmunityBio, Inc.'s book value per share?
ImmunityBio, Inc. (IBRX) reported book value per share of -$0.85 in Q1 2026.
How has ImmunityBio, Inc.'s book value per share changed year-over-year?
ImmunityBio, Inc.'s book value per share decreased by 22.2% year-over-year, from -$0.69 to -$0.85.
What is the long-term trend for ImmunityBio, Inc.'s book value per share?
Over 5 years (2020 to 2025), ImmunityBio, Inc.'s book value per share has grown at a -13.2% compound annual growth rate (CAGR), from -$1.10 to -$0.54.
What does book value per share mean?
Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.

Ask your AI about ImmunityBio, Inc.'s book value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude